Cargando…
Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies
In an ever-increasing aged world, Alzheimer’s disease (AD) represents the first cause of dementia and one of the first chronic diseases in elderly people. With 55 million people affected, the WHO considers AD to be a disease with public priority. Unfortunately, there are no final cures for this path...
Autores principales: | Buccellato, Francesca R., D’Anca, Marianna, Tartaglia, Gianluca Martino, Del Fabbro, Massimo, Scarpini, Elio, Galimberti, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531090/ https://www.ncbi.nlm.nih.gov/pubmed/37762203 http://dx.doi.org/10.3390/ijms241813900 |
Ejemplares similares
-
Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
por: Buccellato, Francesca Romana, et al.
Publicado: (2021) -
Extracellular Vesicles in Multiple Sclerosis: Role in the Pathogenesis and Potential Usefulness as Biomarkers and Therapeutic Tools
por: D’Anca, Marianna, et al.
Publicado: (2021) -
The Role of Glymphatic System in Alzheimer’s and Parkinson’s Disease Pathogenesis
por: Buccellato, Francesca R., et al.
Publicado: (2022) -
Circular RNAs: Emblematic Players of Neurogenesis and Neurodegeneration
por: D’Anca, Marianna, et al.
Publicado: (2022) -
Beyond dentistry: could prevention and screening for neurodegenerative diseases start in the dental office?
por: Buccellato, Francesca R., et al.
Publicado: (2023)